Change from baseline and analysis of covariance revisited

Statistics in Medicine

Volumn 25, Issue 24, 2006, Pages 4334-4344

  Senn, Stephen ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Analysis of covariance; Baselines; Change score; Lord's paradox; Repeated measures

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL RESEARCH; DIASTOLIC BLOOD PRESSURE; EXPERIMENTAL DESIGN; HEALTH STATISTICS; HYPERTENSION; NORMAL DISTRIBUTION; PATIENT SELECTION; STATISTICAL MODEL; SYSTEMATIC ERROR; THERAPY EFFECT;

ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BIOMEDICAL RESEARCH; BLOOD PRESSURE; DATA INTERPRETATION, STATISTICAL; HUMANS; HYPERTENSION;

EID: 33845892180     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2682     Document Type: Article

References (29)

1. Senn SJ. The use of baselines in clinical trials of bronchodilators. Statistics in Medicine 1989; 8:1339-1350.
2. Senn SJ. Covariate imbalance and random allocation in clinical trials [see comments]. Statistics in Medicine 1989; 8:467-475.
3. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design [see comments]. Statistics in Medicine 1992; 11:1685-1704.
4. Frison U, Pocock SJ. Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics. Statistics in Medicine 1997; 16:2855-2872.
5. Chambless LE, Roeback JR. Methods for assessing difference between groups in change when initial measurements is subject to intra-individual variation. Statistics in Medicine 1993; 12:1213-1237.
6. Senn SJ. Methods for assessing difference between groups in change when initial measurement is subject to intra-individual variation [letter; comment] [see comments]. Statistics in Medicine 1994; 13:2280-2285.
7. Senn SJ. In defence of analysis of covariance: a reply to Chambless and Roeback [letter; comment]. Statistics in Medicine 1995; 14:2283-2285.
8. Senn SJ. Covariance analysis in generalized linear measurement error models [letter; comment]. Statistics in Medicine 1990; 9:583-586.
9. Senn SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design [letter; comment]. Statistics in Medicine 1994; 13:197-198.
10. Liang KY, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhya - The Indian Journal of Statistics Series B 2000; 62:134-148.
11. Samuels ML. Use of analysis of covariance in clinical trials: a clarification. Controlled Clinical Trials 1986; 7:325-329.
12. Laird N. Further comparative analyses of pre-test post-test research designs. The American Statistician 1983; 37:329-330.
13. Lord FM. A paradox in the interpretation of group comparisons. Psychological Bulletin 1967; 66:304-305.
14. Holland PW, Rubin DB. On Lord's Paradox. In Principals of Modern Psychological Measurement, Wainer H, Messick S (eds). Lawrence Erlbaum Associates: Hillsdale, NJ, 1983.
15. Wainer H. Adjusting for differential base rates - Lords Paradox again. Psychological Bulletin 1991; 109:147-151.
16. Wainer H, Brown LM. Two statistical paradoxes in the interpretation of group differences: illustrated with medical school admission and licensing data. American Statistician 2004; 58:117-123.
17. Senn SJ. Statistical Issues in Drug Development. Wiley: Chichester, 1997.
18. Rubin DB. Estimating causal effects of treatment in randomized and nonrandomized studies. Journal of Educational Psychology 1974; 66:688-701.
19. Dawid AP. Causal inference without counterfactuals. Journal of the American Statistical Association 2000; 95:407-424.
20. Rubin DB. Assignment to treatment group on the basis of a covariate. Journal of Educational Statistics 1977; 2: 1-26.
21. Senn SJ. The many modes of meta. Drug Information Journal 2000; 34:535-549.
22. Senn SJ. Added values: controversies concerning randomization and additivity in clinical trials. Statistics in Medicine 2004; 23:3729-3753.
23. Senn SJ. A personal view of some controversies in allocating treatment to patients in clinical trials [see comments]. Statistics in Medicine 1995; 14:2661-2674.
24. Campbell DT, Stanley JC. Experimental and Quasi-experimental Designs for Research. Rand McNally: Chicago, 1966.
25. Trochim WM, Cappelleri JC. Cutoff assignment strategies for enhancing randomized clinical trials. Controlled Clinical Trials 1992; 13:190-212.
26. Oldham P. A note on the analysis of repeated measurements of the same subjects. Journal of Chronic Diseases 1962; 15:969-977.
27. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
28. Laird NM, Wang F. Estimating rates of change in randomized clinical trials. Controlled Clinical Trials 1990; 11:405-419.
29. Senn SJ, Stevens L, Chaturvedi N. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Statistics in Medicine 2000; 19:861-877.